Insights
Healthcare growth runs on a new operating model
For most of the last decade, AI in healthcare was sold as an enabler. The companies that win the next phase will treat it as a growth driver. Speed to market, customer engagement at scale, depth of personalization. None of which regulated markets have delivered.
Shared Accountability Is No Accountability
Most established pharma orgs stall at the ownership question before they ever get to the work.
Pharma's AI Retrofit Ceiling
Most AI pilots aren't broken. The legacy commercial model underneath is. Here's what the data shows, and the structural ceiling most established pharma commercial orgs are about to hit.